Viridian Therapeutics
Price & Volume
Stats
See moreOpen | $28.23 |
Previous Close | $28.07 |
Day Range | $28.23-$29.48 |
52W Range | $9.90-$34.29 |
Market Cap | $2.6B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $70.7M |
Revenue Growth (YoY) | 81,958.1% |
Gross Profit (12 Mos) | -$247.3M |
Diluted EPS | -$3.03 |
News
See moreYahoo Finance • 2 months ago
Huge Insider Buying in MGM and Salesforce
Yahoo Finance • 3 months ago
Viridian Metals Announces Closing of First Tranche of Financing and Short Form Vertical Amalgamation
Yahoo Finance • 5 months ago
Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4)
Yahoo Finance • 7 months ago
Viridian licenses thyroid eye disease treatments to Kissei in Japan
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 143 |
